$908 Million is the total value of Rhenman & Partners Asset Management AB's 88 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 20.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Buy | Vertex Pharmaceuticals Inc | $33,968,000 | +27.9% | 185,232 | +28.3% | 3.74% | +20.4% |
| HUM | Buy | Humana Inc | $27,857,000 | +36.0% | 105,000 | +36.4% | 3.07% | +28.0% |
| JAZZ | Jazz Pharmaceuticals Plc | $26,683,000 | -0.3% | 187,171 | 0.0% | 2.94% | -6.1% | |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $26,591,000 | +44.1% | 203,017 | +48.8% | 2.93% | +35.7% |
| HBNC | New | Horizon Therapeutics Plc | $26,169,000 | – | 1,087,656 | +100.0% | 2.88% | – |
| NKTR | Sell | Nektar Therapeutics | $25,796,000 | +4.5% | 725,000 | -1.3% | 2.84% | -1.6% |
| UNH | Sell | United Health Group Inc | $25,621,000 | -16.0% | 105,000 | -14.9% | 2.82% | -20.9% |
| ANTM | Buy | Anthem Inc | $25,399,000 | +20.2% | 90,000 | +22.2% | 2.80% | +13.2% |
| ABMD | Buy | Abiomed Inc | $24,200,000 | -8.4% | 92,900 | +0.4% | 2.67% | -13.7% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $24,098,000 | +17.2% | 281,349 | +21.5% | 2.65% | +10.3% |
| NVCR | Sell | NovoCure Ltd Reg | $23,136,000 | +5.6% | 365,899 | -19.5% | 2.55% | -0.5% |
| ABT | Abbott Laboratories | $21,828,000 | +5.2% | 259,552 | 0.0% | 2.40% | -0.9% | |
| BDX | Buy | Becton Dickinson & Co | $20,161,000 | +7.6% | 80,000 | +6.7% | 2.22% | +1.4% |
| ESPR | Sell | Esperion Therapeutics Inc | $19,171,000 | -0.5% | 412,093 | -14.1% | 2.11% | -6.3% |
| MRTX | Buy | Mirati Therapeutics Inc Reg | $18,747,000 | +101.2% | 182,008 | +43.2% | 2.06% | +89.4% |
| CVS | Sell | CVS Health Corp | $18,732,000 | -1.8% | 343,768 | -2.9% | 2.06% | -7.6% |
| IOVA | Sell | Iovance Biotherapeutics Inc Reg | $18,407,000 | +120.0% | 750,700 | -14.7% | 2.03% | +107.4% |
| HCA | New | HCA Healthcare Inc | $18,405,000 | – | 136,164 | +100.0% | 2.03% | – |
| GKOS | Buy | Glaukos Corp | $17,788,000 | -3.7% | 235,911 | +0.1% | 1.96% | -9.3% |
| LLY | Buy | Eli Lilly & Co | $17,726,000 | +38.4% | 160,000 | +62.1% | 1.95% | +30.4% |
| BSX | Buy | Boston Scientific Corp | $16,672,000 | +18.1% | 387,908 | +5.4% | 1.84% | +11.1% |
| MDT | Sell | Medtronic Plc Reg | $15,863,000 | +3.2% | 162,883 | -3.5% | 1.75% | -2.9% |
| FGEN | Buy | FibroGen Inc | $15,697,000 | +52.4% | 347,439 | +83.4% | 1.73% | +43.5% |
| CNC | Buy | Centene Corp | $15,470,000 | +45.7% | 295,000 | +47.5% | 1.70% | +37.2% |
| BMY | Buy | Bristol Myers Squibb Co | $15,346,000 | +39.9% | 338,386 | +47.1% | 1.69% | +31.7% |
| NBIX | Buy | Neurocrine Biosciences Inc | $15,197,000 | -2.6% | 180,000 | +1.6% | 1.67% | -8.3% |
| CI | Sell | Cigna Corp Reg | $15,155,000 | -41.0% | 96,191 | -39.8% | 1.67% | -44.4% |
| MGNX | Sell | Macrogenics Inc | $14,546,000 | -16.4% | 857,169 | -11.4% | 1.60% | -21.2% |
| REGN | Buy | Regeneron Pharmaceuticals Inc | $14,089,000 | +114.4% | 45,014 | +181.3% | 1.55% | +102.1% |
| XNCR | Sell | Xencor Inc | $13,089,000 | +29.3% | 319,792 | -1.9% | 1.44% | +21.8% |
| ITCI | Intra-Cellular Therapies Inc | $12,329,000 | +6.6% | 949,833 | 0.0% | 1.36% | +0.4% | |
| ABC | Buy | AmerisourceBergen Corp | $12,066,000 | +30.2% | 141,520 | +21.5% | 1.33% | +22.6% |
| IMMU | Buy | Immunomedics Inc | $11,808,000 | -0.3% | 851,367 | +38.1% | 1.30% | -6.1% |
| MYOK | MyoKardia Inc Reg | $11,283,000 | -3.6% | 225,024 | 0.0% | 1.24% | -9.1% | |
| LIVN | Sell | Livanova Plc | $10,794,000 | -53.9% | 150,000 | -37.7% | 1.19% | -56.6% |
| EXAS | Sell | Exact Sciences Corp Reg | $10,624,000 | +22.7% | 90,000 | -10.0% | 1.17% | +15.5% |
| AGIO | Buy | Agios Pharmaceuticals Inc | $9,976,000 | +16.5% | 200,000 | +57.5% | 1.10% | +9.7% |
| ARNA | Sell | Arena Pharmaceuticals Inc Reg | $9,967,000 | -5.2% | 170,000 | -27.5% | 1.10% | -10.7% |
| EXEL | Buy | Exelixis Inc | $9,830,000 | -3.9% | 460,000 | +7.0% | 1.08% | -9.5% |
| SGEN | Sell | Seattle Genetics Inc Reg | $9,369,000 | -15.1% | 135,374 | -10.1% | 1.03% | -20.0% |
| BLUE | Buy | Bluebird Bio Inc | $8,904,000 | +2.9% | 70,000 | +27.3% | 0.98% | -3.1% |
| TMO | Sell | Thermo Fisher Scientific Inc | $8,752,000 | +6.6% | 29,800 | -0.7% | 0.96% | +0.3% |
| OMCL | Omnicell Inc | $8,635,000 | +6.4% | 100,375 | 0.0% | 0.95% | +0.2% | |
| CHRS | Sell | Coherus BioSciences Inc | $8,619,000 | +40.1% | 390,000 | -13.6% | 0.95% | +31.8% |
| SGMO | Sell | Sangamo Therapeutics Inc Reg | $8,551,000 | +6.2% | 793,957 | -5.9% | 0.94% | 0.0% |
| INCY | Incyte Corp Ltd | $8,496,000 | -1.2% | 100,000 | 0.0% | 0.94% | -7.0% | |
| GTHX | Buy | G1 Therapeutics Inc Reg | $8,409,000 | +138.8% | 274,274 | +29.3% | 0.93% | +124.8% |
| AERI | Aerie Pharmaceuticals Inc | $7,683,000 | -37.8% | 260,000 | 0.0% | 0.85% | -41.5% | |
| STML | New | Stemline Therapeutics Inc Reg | $7,568,000 | – | 493,999 | +100.0% | 0.83% | – |
| DPLO | Diplomat Pharmacy Inc Reg | $7,329,000 | +4.8% | 1,203,405 | 0.0% | 0.81% | -1.3% | |
| MDCO | Buy | Medicines Co | $7,294,000 | +100.7% | 200,000 | +53.8% | 0.80% | +88.9% |
| RARX | Buy | Ra Pharmaceuticals Inc Reg | $6,886,000 | +104.9% | 229,000 | +52.7% | 0.76% | +92.9% |
| AMRN | Sell | Amarin Corp Plc spons ADR repr 1 Sharespons adr new | $6,802,000 | -11.6% | 350,800 | -5.4% | 0.75% | -16.8% |
| EPZM | Buy | Epizyme Inc Reg | $6,196,000 | +744.1% | 493,679 | +733.8% | 0.68% | +693.0% |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $5,917,000 | -30.8% | 81,550 | -10.9% | 0.65% | -34.9% |
| RIGL | Rigel Pharmaceuticals Inc | $5,911,000 | +1.5% | 2,264,942 | 0.0% | 0.65% | -4.4% | |
| VRAY | ViewRay Inc Reg | $5,850,000 | +19.2% | 664,023 | 0.0% | 0.64% | +12.2% | |
| EW | Buy | Edwards Lifesciences Corp | $5,835,000 | +14.7% | 31,585 | +18.8% | 0.64% | +8.1% |
| DVAX | Buy | Dynavax Technologies Corp | $4,925,000 | +136.4% | 1,234,335 | +333.1% | 0.54% | +122.1% |
| DERM | Dermira Inc Reg | $4,783,000 | -29.4% | 500,329 | 0.0% | 0.53% | -33.5% | |
| SAGE | Sell | Sage Therapeutics Inc | $3,962,000 | -51.8% | 21,639 | -58.1% | 0.44% | -54.6% |
| MDGL | Buy | Madrigal Pharmaceuticals Inc Reg | $3,902,000 | +14.4% | 37,225 | +36.7% | 0.43% | +7.8% |
| NSTG | NanoString Technologies Inc Reg | $3,642,000 | +26.8% | 120,000 | 0.0% | 0.40% | +19.3% | |
| HMSY | New | HMS Holdings Corp Reg | $3,239,000 | – | 100,000 | +100.0% | 0.36% | – |
| ABEO | Abeona Therapeutics Inc Reg | $3,103,000 | -35.1% | 649,123 | 0.0% | 0.34% | -38.8% | |
| AIMT | Aimmune Therapeutics Inc Reg | $3,106,000 | -6.9% | 149,201 | 0.0% | 0.34% | -12.3% | |
| ICPT | New | Intercept Pharmaceuticals Inc | $2,992,000 | – | 37,600 | +100.0% | 0.33% | – |
| XLRN | Acceleron Pharma Inc Reg | $2,876,000 | -11.8% | 70,000 | 0.0% | 0.32% | -16.8% | |
| ALKS | Alkermes Plc | $2,714,000 | -38.2% | 120,399 | 0.0% | 0.30% | -41.8% | |
| RVNC | Revance Therapeutics Inc | $2,506,000 | -17.7% | 193,181 | 0.0% | 0.28% | -22.5% | |
| QGEN | Qiagen NV Reg | $2,438,000 | +0.1% | 60,000 | 0.0% | 0.27% | -5.6% | |
| VKTX | New | Viking Therapeutics Inc Reg | $2,419,000 | – | 291,499 | +100.0% | 0.27% | – |
| ADVM | Adverum Biotechnologies Inc | $1,423,000 | +127.0% | 119,673 | 0.0% | 0.16% | +115.1% | |
| PIRS | Pieris Pharmaceuticals Inc Reg | $1,410,000 | +40.3% | 300,000 | 0.0% | 0.16% | +31.4% | |
| ONCE | New | Spark Therapeutics Inc | $1,024,000 | – | 10,000 | +100.0% | 0.11% | – |
| ACHN | Achillion Pharmaceuticals Inc | $745,000 | -9.4% | 277,800 | 0.0% | 0.08% | -14.6% | |
| CVX | Sell | Chevron Corp | $370,000 | -19.6% | 2,974 | -20.3% | 0.04% | -24.1% |
| IBM | Sell | IBM Corp | $305,000 | -12.1% | 2,215 | -10.0% | 0.03% | -17.1% |
| BUD | Sell | Anheuser-Busch InBev SA ADR spons repr 1 Sharesponsored adr | $302,000 | -5.0% | 3,409 | -10.0% | 0.03% | -10.8% |
| F | Sell | Ford Motor Co | $298,000 | +4.6% | 29,164 | -10.0% | 0.03% | 0.0% |
| XOM | Sell | Exxon Mobil Corp | $295,000 | -40.3% | 3,854 | -36.9% | 0.03% | -44.8% |
| DIS | Sell | The Walt Disney Co | $291,000 | -24.8% | 2,083 | -40.2% | 0.03% | -28.9% |
| SNSS | Sunesis Pharmaceuticals Inc Reg | $274,000 | -40.2% | 377,244 | 0.0% | 0.03% | -44.4% | |
| JPM | Sell | JPMorgan Chase & Co | $276,000 | -0.7% | 2,472 | -10.0% | 0.03% | -9.1% |
| QCOM | Sell | Qualcomm Inc | $258,000 | -30.1% | 3,391 | -47.6% | 0.03% | -34.9% |
| WFC | Sell | Wells Fargo & Co | $249,000 | -12.0% | 5,272 | -10.0% | 0.03% | -18.2% |
| JHG | Sell | Janus Henderson Group Plc Reg | $228,000 | -22.7% | 10,645 | -10.0% | 0.02% | -28.6% |
| MSFT | Sell | Microsoft Corp | $205,000 | -39.7% | 1,532 | -46.9% | 0.02% | -42.5% |
| CMRX | Exit | Chimerix Inc | $0 | – | -68,832 | -100.0% | -0.02% | – |
| GOOGL | Exit | Alphabet Inc Acap stk cl a | $0 | – | -178 | -100.0% | -0.02% | – |
| PFE | Exit | Pfizer Inc | $0 | – | -5,009 | -100.0% | -0.02% | – |
| SYMC | Exit | Symantec Corp | $0 | – | -9,734 | -100.0% | -0.03% | – |
| HAL | Exit | Halliburton Co (Hg Co) | $0 | – | -9,221 | -100.0% | -0.03% | – |
| FLXN | Exit | Flexion Therapeutics Inc | $0 | – | -117,265 | -100.0% | -0.17% | – |
| ABBV | Exit | AbbVie Inc | $0 | – | -60,000 | -100.0% | -0.57% | – |
| CELG | Exit | Celgene Corp | $0 | – | -65,698 | -100.0% | -0.72% | – |
| WBA | Exit | Walgreens Boots Alliance Inc | $0 | – | -145,000 | -100.0% | -1.07% | – |
| AGN | Exit | Allergan Plc | $0 | – | -88,600 | -100.0% | -1.52% | – |
| ARRY | Exit | Array BioPharma Inc | $0 | – | -607,070 | -100.0% | -1.73% | – |
| HZNP | Exit | Horizon Pharma Plc | $0 | – | -939,973 | -100.0% | -2.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-07-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.